Experts at UT MD Anderson have numerous presentations throughout the 2025 ASH Annual Meeting. All times listed in Eastern Time.
Experts at UT MD Anderson have numerous presentations throughout the 2025 ASH Annual Meeting. All times listed in Eastern Time.
Friday, December 5
Scientific Workshops
3:00每6:00 p.m.
Orange County Convention Center W312
A New Horizon in Hematology: Novel Strategies for Reversing Aging
5:16每5:57 p.m.
Speaker: Daisy Diaz-Rohena, Ph.D.
Panel discussion and cross-examination of the position; post-session polling
3:00每6:00 p.m.
Orange County Convention Center W307
Disease Models and Mechanisms: Bridging the Gap
3:06每3:48 p.m.
Speaker:
Saturday, December 6
Oral Abstract Sessions
9:30每11:00 a.m.
Orange County Convention Center Valencia Room W415A
Abstract 45:
Speaker: Roberta Santos Azevedo, M.D.
Abstract 47:
Speaker:
9:30每11:00 a.m.
Orange County Convention Center W224ABEF
Abstract 89:
Speaker:
9:30每11:00 a.m.
Orange County Convention Center West Hall E2
Abstract 137:
Speaker:
12:00每1:30 p.m.
Orange County Convention Center Tangerine Ballroom F2
Abstract 153:
Speaker:
12:00每1:30 p.m.
Orange County Convention Center Chapin Theater (W320)
Abstract 162:
Speaker: Eiko Hayase, M.D.
12:00每1:30 p.m.
Orange County Convention Center W331
Abstract 168:
Speaker:
2:00每3:30 p.m.
Orange County Convention Center W304ABCD
Abstract 196:
Speaker:
2:00每3:30 p.m.
Orange County Convention Center W414AB
Abstract 222:
Speaker: Yi June Kim
2:00每3:30 p.m.
Orange County Convention Center Valencia Room W415BC
Abstract 235:
Speaker:
Abstract 237:
Speaker:
2:00每3:30 p.m.
Orange County Convention Center West Hall E1
Abstract 256:
Speaker:
2:00每3:30 p.m.
Abstract 263:
Presenter:
4:00每5:30 p.m.
Orange County Convention Center W230
Abstract 330:
Speaker:
4:00每5:30 p.m.
Orange County Convention Center Sunburst Room (W340)
Abstract 378:
Speaker:
4:00每5:30 p.m.
Orange County Convention Center W331
Abstract 388:
Speaker:
Abstract 390:
Speaker:
Education Program
Complementopathies: Modern Diagnosis and Management
2:00每3:15 p.m.
Hyatt Regency Ballroom S
Speaker:
Blood Journals Studio
2:00每2:45 p.m.
Orange County Convention Center West Halls B3每B4
Speaker:
Scientific Program
2:00每3:15 p.m.
Orange County Convention Center West Hall E2
Speaker:
Special-Interest Sessions
4:00每5:30 p.m.
Hyatt Regency Ballroom S
Speaker:
6:30每8 p.m.
Hyatt Florida Ballroom A
6:30每8:00 p.m.
Speaker:
Sunday, December 7
Oral Abstract Sessions
9:30每11:00 a.m.
Orange County Convention Center Tangerine Ballroom F1
Abstract 460:
Speaker: Minghao Dang
9:30每11:00 a.m.
Orange County Convention Center West Hall D2
Abstract 467:
Speaker:
9:30每11:00 a.m.
Orange County Convention Center Tangerine Ballroom F3-4
Abstract 477:
Speaker:
9:30每11:00 a.m.
Orange County Convention Center Valencia Room W415D
Abstract 487:
Speaker:
Abstract 489:
Speaker:
Abstract 491:
Speaker:
9:30每11:00 a.m.
Orange County Convention Center W230
Abstract 517:
Speaker: Vanthana Bharathi
12:00每1:30 p.m.
Orange County Convention Center W224ABEF
Abstract 549:
Speaker: Roberta Santos Azevedo, M.D.
Abstract 551:
Speaker: Manuel Maroun, M.D.
12:00-1:30 p.m.
Orange County Convention Center Tangerine Ballroom F1
Abstract 555:
Speaker: Tania Sainz
12:00每1:30 p.m.
Orange County Convention Center W331
Abstract 592:
Speaker:
12:00每1:30 p.m.
Orange County Convention Center W304ABCD
Moderator:
12:00每1:30 p.m.
Orange County Convention Center W414CD
Abstract 604:
Speaker: Vaishali Gautam
4:30每6:00 p.m.
Orange County Convention Center Chapin Theater (W320)
Abstract 651:
Speaker:
Abstract 651:
Speaker:
4:30每6:00 p.m.
Orange County Convention Center Tangerine Ballroom F2
Abstract 663:
Speaker:
Abstract 665:
Speaker:
Abstract 666:
Speaker: Preetesh Jain, M.B.B.S., M.D., D.M., Ph.D.
4:30每6:00 p.m.
Orange County Convention Center Tangerine Ballroom F3-4
Abstract 670:
Speaker:
4:30每6:00 p.m
Orange County Convention Center Valencia Room W415A
Abstract 674:
Speaker: Yu-Hsiang Chen, Ph.D.
4:30每6:00 p.m.
Orange County Convention Center W224ABEF
Abstract 680:
Speaker:
Abstract 680:
Speaker:
Abstract 681:
Speaker:
4:30每6:00 p.m.
Orange County Convention Center West Hall E1
Abstract 697:
Speaker:
4:30每6:00 p.m.
Orange County Convention Center West Hall D1
Abstract 716:
Speaker: Muhammad Bilal Abid, M.D.
4:30每6:00 p.m.
Orange County Convention Center W414CD
Abstract 725:
Speaker:
Scientific Spotlight Session
4:30每5:45 p.m.
Orange County Convention Center Sunburst Room (W340)
Strategies to reduce immune rejection of off-the-shelf cell therapies
Co-Chair and Speaker:
ASH Poster Walk
8:00每9:00 a.m.
Orange County Convention Center West Halls B3-B4
Chair:
Monday, December 8
Oral Abstract Sessions
10:30 a.m.每12:00 p.m.
Orange County Convention Center W224CDGH
Abstract 759:
Speaker: Sankalp Arora, M.B.B.S.
10:30 a.m.每12:00 p.m.
Orange County Convention Center Chapin Theater (W320)
Abstract 763:
Speaker:
10:30 a.m.每12:00 p.m.
Orange County Convention Center Tangerine Ballroom F1
Abstract 775:
Speaker:
10:30 a.m.每12:00 p.m.
Orange County Convention Center Valencia Room W415A
Abstract 790:
Speaker:
10:30 a.m.每12:00 p.m.
Orange County Convention Center W331
Abstract 806:
Speaker:
10:30 a.m.每12:00 p.m.
Orange County Convention Center West Hall E2
Abstract 823:
Speaker:
Abstract 824:
Speaker:
2:45每4:15 p.m.
Orange County Convention Center Tangerine Ballroom F1
Abstract 885:
Speaker:
2:45每4:15 p.m.
Orange County Convention Center Tangerine Ballroom F3-4
Abstract 895:
Speaker:
2:45每4:15 p.m.
Orange County Convention Center Chapin Theater (W320)
Abstract 901:
Speaker:
2:45每4:15 p.m.
Orange County Convention Center W331
Abstract 932:
Speaker:
4:30每6:00 p.m.
Orange County Convention Center Chapin Theater (W320)
Abstract 977:
Speaker: Roberta Santos Azevedo, M.D.
Wednesday, December 10
ASH Poster Walk
10:00每11:00 a.m.
ASH Virtual Platform
Chair:
Posters
Saturday, December 6
Poster Abstract Sessions
5:30每7:30 p.m.
Orange County Convention Center West Halls B3每B4
114. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I
Abstract 1174:
Presenter: Kaung Htet Hla Win, M.B.
Abstract 1196:
Presenter: Kaung Htet Hla Win, M.B.
401. Blood Transfusion: Poster I
Abstract 1368:
Presenter: Hila Shaim, M.D., Ph.D.
509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster I
Abstract 1435:
Presenter: Leticia Campoverde, M.D.
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster I
Abstract 1496:
Presenter: Saurabh Kumar Gupta, Ph.D.
Abstract 1497:
Presenter:
Abstract 1500:
Presenter:
Abstract 1510:
Presenter:
Abstract 1513:
Presenter: Anna Sergeeva, Ph.D.
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I
Abstract 1558:
Presenter: Trevor Jamison, M.D.
Abstract 1556:
Presenter: Hannah Goulart, M.D.
Abstract 1544:
Presenter: Grace Park, Pharm.D.
613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I
Abstract 1566:
Presenter: Hannah Goulart, M.D.
Abstract 1567:
Presenter: Hannah Goulart, M.D.
Abstract 1571:
Presenter: Hannah Goulart, M.D.
Abstract 1573:
Presenter:
Abstract 1578:
Presenter: Koji Sasaki, M.D., Ph.D.
614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Measurable Residual Disease in Diagnosis and Prognosis: Poster I
Abstract 1593:
Presenter: Samanta Catueno, M.D.
615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster I
Abstract 1620:
Presenter: Michelle Nwachukwu, D.O.
Abstract 1630:
Presenter: Roberta Santos Azevedo, M.D.
Abstract 1634:
Presenter: Roberta Santos Azevedo, M.D.
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster I
Abstract 1641:
Presenter:
Abstract 1642:
Presenter:
Abstract 1646:
Presenter:
Abstract 1652:
Presenter:
Abstract 1653:
Presenter:
617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster I
Abstract 1678:
Presenter: Hannah Goulart, M.D.
Abstract 1688:
Presenter: Farah Al Haj, M.D.
618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster I
Abstract 1724:
Presenter:
Abstract 1726:
Presenter: Roberta Santos Azevedo, M.D.
621. Lymphomas: Translational 每 Molecular and Genetic: Poster I
Abstract 1764:
Presenter: Fangfang Yan, Ph.D.
Abstract 1765:
Presenter: Fangfang Yan, Ph.D.
622. Lymphomas: Translational - Non-Genetic: Poster I
Abstract 1785:
Presenter: Yixin Yao
623. Mantle Cell, Follicular, Waldenstrom's and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I
Abstract 1829:
Presenter:
Abstract 1837:
Presenter:
624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster I
Abstract 1844:
Presenter:
Abstract 1852:
Presenter: Karan Chohan
625. T Cell, NK Cell or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I
Abstract 1869:
Presenter:
Abstract 1872:
Presenter: Swami Iyer, M.D.
628. Aggressive Lymphomas: Cellular Therapies: Poster I
Abstract 1931:
Presenter:
629. Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Poster I
Abstract 1967:
Presenter: Kunhwa Kim, M.D.
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I
Abstract 1983:
Presenter:
Abstract 3759:
Presenter: Linda Fabris, Ph.D.
632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I
Abstract 2010:
Presenter: Mina Abdelmalek, M.D.
Abstract 1539:
Presenter: Mikaela Garza
634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I
Abstract 2037:
Presenter: Hannah Goulart, M.D.
637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster I
Abstract 2075:
Presenter:
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I
Abstract 2115: Presenter:
701. Experimental Transplantation: Basic and Translational: Poster I
Abstract 2306:
Presenter:
702. CAR T Cell Therapies: Basic and Translational: Poster I
Abstract 2337:
Presenter: Cuong Le, Ph.D.
732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I
Abstract 2511:
Presenter:
Abstract 2515:
Presenter:
Abstract 4294:
Presenter:
903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I
Abstract 2648:
Presenter:
906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I
Abstract 2713:
Presenter: Zachary Hunzeker, M.D.
Abstract 2716:
Presenter: Bryan Valcarcel, M.D.
Abstract 2719:
Presenter: Rahul Shah, M.D.
908. Outcomes Research: Myeloid Malignancies: Poster I
Abstract 2836:
Presenter:
Sunday, December 7
Poster Abstract Sessions
Orange County Convention Center West Halls B3每B4
6:00每8:00 p.m.
102. Iron Homeostasis and Biology in Physiological and Pathological Conditions: Poster II
Abstract 2906:
Presenter: Reeja Raj
201. Granulocytes, Monocytes, and Macrophages: Poster II
Abstract 2980:
Presenter: Mitchell Boshkos, D.O.
323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster II
Abstract 3091:
Presenter: Sidra Naz, M.D.
332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II
Abstract 3131:
Presenter: Jhoan Sebastian Gonzalez Diaz, M.D.
503. Clonal Hematopoiesis, Aging, and Inflammation: Poster II
Abstract 3160:
Presenter:
508. Bone Marrow Failure: Acquired: Poster II
Abstract 3206:
Presenter:
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster II
Abstract 3266:
Presenter:
Abstract 3276:
Presenter:
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II
Abstract 3314:
Presenter:
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II
Abstract 3326:
Presenter:
613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster II
Abstract 3348:
Presenter: Hannah Goulart, M.D.
Abstract 3350:
Presenter: Hannah Goulart, M.D.
614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Measurable Residual Disease in Diagnosis and Prognosis: Poster II
Abstract 3370:
Presenter:
615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II
Abstract 3397:
Presenter: Sankalp Arora, M.B.B.S.
Abstract 3399:
Presenter: Jennifer Marvin-Peek, M.D.
Abstract 3405:
Presenter: Vanthana Bharathi
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster II
Abstract 3428:
Presenter:
Abstract 3429:
Presenter:
617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster II
Abstract 3459:
Presenter: Niranjan Khaire, M.B.B.S., M.D., D.M.
Abstract 3461:
Presenter:
618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster II
Abstract 3492:
Presenter:
Abstract 3503:
Presenter: Sara Nofal, M.D., Ph.D.
621. Lymphomas: Translational 每 Molecular and Genetic: Poster II
Abstract 3545:
Presenter:
623. Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster II
Abstract 3571:
Presenter:
625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II
Abstract 3653:
Presenter: Roberta Santos Azevedo, M.D.
628. Aggressive Lymphomas: Cellular Therapies: Poster II
Abstract 3717:
Presenter:
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II
Abstract 3758:
Presenter: Wei Xiao, Ph.D.
634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II
Abstract 3795:
Presenter:
Abstract 3803:
Presenter:
Abstract 3813:
Presenter: Annie Hoai Nguyen
625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II
Abstract 3636:
Presenter: Bryan Valcarcel, M.D.
627. Aggressive Lymphomas: Targeted and Pharmacologic Therapies: Poster II
Abstract 3691:
Presenter: Eduardo Edelman Saul, M.D.
628. Aggressive Lymphomas: Cellular Therapies: Poster II
Abstract 3709:
Presenter: Jinsheng Weng, M.D., Ph.D.
634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II
Abstract 8947:
Presenter:
636. Myelodysplastic Syndromes: Basic and Translational: Poster II
Abstract 3832:
Presenter:
Abstract 3839:
Presenter: Hui Yang, Ph.D.
637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II
Abstract 3848:
Presenter:
Abstract 3849:
Presenter:
Abstract 3867:
Presenter:
Abstract 3874:
Presenter:
907. Outcomes Research: Plasma Cell Disorders: Poster II
Abstract 4575:
Presenter: Christen Dillard, M.D.
908. Outcomes Research: Myeloid Malignancies: Poster II
Abstract 4613:
Presenter:
Abstract 4634:
Presenter:
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster II
Abstract 3892:
Presenter:
653. Multiple Myeloma: Clinical and Epidemiological: Poster II
Abstract 3987:
Presenter:
637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II
Abstract 3857:
Presenter: Roberta Santos Azevedo, M.D.
703. Cellular Immunotherapies other than CAR-T Cells: Poster II
Abstract 4137:
Presenter: Sandeep Singh, Ph.D.
704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II
Abstract 4148:
Presenter:
903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II
Abstract 4435:
Presenter: Ummul Asfeen, D.O.
905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II
Abstract 4470:
Presenter: Yin Mon Myat, M.B., B.Ch.
906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster II
Abstract 4482:
Presenter: Preetesh Jain, M.B.B.S., M.D., D.M., Ph.D.
908. Outcomes Research: Myeloid Malignancies: Poster II
Abstract 4605:
Presenter:
Monday, December 8
Poster Abstract Sessions
Orange County Convention Center West Halls B3每B4
6:00每8:00 p.m.
332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster III
Abstract 4909:
Presenter: Elyse Cortez, M.D.
503. Clonal Hematopoiesis, Aging and Inflammation: Poster III
Abstract 4952:
Presenter: Shelley Herbrich, Ph.D.
506. Bone Marrow Microenvironment: Poster III
Abstract 4957:
Presenter: Olayinka Okeleji, M.D.
602. Myeloid Oncogenesis: Basic: Poster III
Abstract 5028:
Presenter:
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III
Abstract 5050:
Presenter: Kazuharu Kamachi, M.D., Ph.D.
Abstract 5053:
Presenter:
Abstract 5055:
Presenter: Priyanka Sharma, Ph.D.
Abstract 5057:
Presenter: Liang Zhang, Ph.D.
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster III
Abstract 5112:
Presenter: Vanthana Bharathi
613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster III
Abstract 5117:
Presenter:
Abstract 5131:
Presenter: Hannah Goulart, M.D.
614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Measurable Residual Disease in Diagnosis and Prognosis: Poster III
Abstract 5150:
Presenter: Niranjan Khaire, M.B.B.S., M.D., D.M.
Abstract 5151:
Presenter:
615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III
Abstract 5156:
Presenter: Reeja Raj, D.O.
Abstract 5167:
Presenter: Sankalp Arora, M.B.B.S.
Abstract 5179:
Presenter: William Marrero, M.D.
616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III
Abstract 5194:
Presenter:
Abstract 5195:
Presenter:
Abstract 5204:
Presenter: Hannah Goulart, M.D.
617. Acute Myeloid Leukemias: Commercially Available Therapies: Poster III
Abstract 9686:
Presenter: Sankalp Arora, M.B.B.S.
618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Poster III
Abstract 5258:
Presenter:
Abstract 5273:
Presenter:
623. Mantle Cell, Follicular, Waldenstrom's and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III
Abstract 5369:
Presenter:
Abstract 5393:
Presenter: Tony Zhuang, M.D.
Abstract 5422:
Presenter:
625. T Cell, NK Cell or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster III
Abstract 5422:
Presenter: Eduardo Edelman Saul, M.D.
Abstract 5432:
Presenter:
Abstract 5434:
Presenter: Eduardo Edelman Saul, M.D.
628. Aggressive Lymphomas: Cellular Therapies: Poster III
Abstract 5485:
Presenter:
Abstract 5500:
Presenter: Muhammad Bilal Abid, M.D.
629. Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Poster III
Abstract 5525:
Presenter: Rahul Shah, M.D.
Abstract 5520:
Presenter: Karan Chohan
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III
Abstract 5526:
Presenter:
Abstract 5542:
Presenter:
632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III
Abstract 5550:
Presenter:
Abstract 5564:
Presenter:
Abstract 5565:
Presenter:
634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III
Abstract 5602:
Presenter:
636. Myelodysplastic Syndromes: Basic and Translational: Poster III
Abstract 5613:
Presenter:
637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster III
Abstract 5641:
Presenter:
Abstract 5644:
Presenter:
Abstract 5645:
Presenter: Roberta Santos Azevedo. M.D.
Abstract 5647:
Presenter:
Abstract 5648:
Presenter: Vanthana Bharathi
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III
Abstract 5685:
Presenter: Alexandra Lovell, Pharm.D.
Abstract 5686:
Presenter: Vishrut Shah, M.D.
Abstract 5687:
Presenter:
651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III
Abstract 5737:
Presenter: Upasana Ray, Ph.D.
653. Multiple Myeloma: Clinical and Epidemiological: Poster III
Abstract 5769:
Presenter:
654. Multiple Myeloma: Pharmacologic Therapies: Poster III
Abstract 5834:
Presenter:
703. Cellular Immunotherapies other than CAR-T Cells: Poster III
Abstract 5915:
Presenter:
704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III
Abstract 5921:
Presenter:
Abstract 5938:
Presenter:
Abstract 5951:
Presenter: Mark Forsberg, M.D.
721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster III
Abstract 5994:
Presenter:
Abstract 5996:
Presenter:
722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III
Abstract 6022:
Presenter:
723. Allogeneic Transplantation: Long-term Follow-up, Complications and Disease Recurrence: Poster III
Abstract 6058:
Presenter:
901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III
Abstract 6163:
Presenter:
Abstract 6174:
Presenter: Reeja Raj, D.O.
906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III
Abstract 6299:
Presenter: Lohitha Dhulipalla, M.D.
Abstract 13008:
Presenter: Rahul Shah, M.D.
908. Outcomes Research: Myeloid Malignancies: Poster III
Abstract 6391:
Presenter:
Abstract 6407:
Presenter:
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at UT?MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.?